$9.01
-0.14-1.53%
At close: -
$9.04
0.030.33%
After Hours: 7:46 PM EDT
Emergent BioSolutions reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Emergent BioSolutions using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $1.37 | $0.14 | 878.6 % |
Jun 2024 | 2024-08-06 | $-2.32 | $-0.94 | -146.8 % |
Mar 2024 | 2024-05-01 | $0.59 | $-0.83 | 171.1 % |
Dec 2023 | 2024-03-06 | $-0.77 | $-0.19 | -305.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $293.80M | $297.50M | -1.24 % |
Jun 2024 | 2024-08-06 | $254.70M | $190.00M | 34.1 % |
Mar 2024 | 2024-05-01 | $300.40M | $224.50M | 33.8 % |
Dec 2023 | 2024-03-06 | $276.60M | $293.53M | -5.77 % |
Emergent BioSolutions (EBS) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $1.37, which beat the estimate of $0.14.
The Actual Revenue was $293.8M, which missed the estimate of $297.5M.
Browse earnings estimates, EPS, and revenue on all stocks.